Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The lancet oncology 2017-10, Vol.18 (11), p.1493-1501
Hauptverfasser: Tawbi, Hussein A., Burgess, Melissa, Bolejack, Vanessa, Van Tine, Brain A., Schuetze, Scott M., Hu, James, D’Angelo, Sandra, Attia, Steven, Riedel, Richard F., Priebat, Dennis A., Movva, Sujana, Davis, Lara E., Okuno, Scott H., Reed, Damon R., Crowley, John, Butterfield, Lisa H., Salazar, Ruth, Rodriguez-Canales, Jaime, Lazar, Alexander J., Wistuba, Ignacio I., Baker, Laurence H., Maki, Robert G., Reinke, Denise, Patel, Shreyaskumar
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1501
container_issue 11
container_start_page 1493
container_title The lancet oncology
container_volume 18
creator Tawbi, Hussein A.
Burgess, Melissa
Bolejack, Vanessa
Van Tine, Brain A.
Schuetze, Scott M.
Hu, James
D’Angelo, Sandra
Attia, Steven
Riedel, Richard F.
Priebat, Dennis A.
Movva, Sujana
Davis, Lara E.
Okuno, Scott H.
Reed, Damon R.
Crowley, John
Butterfield, Lisa H.
Salazar, Ruth
Rodriguez-Canales, Jaime
Lazar, Alexander J.
Wistuba, Ignacio I.
Baker, Laurence H.
Maki, Robert G.
Reinke, Denise
Patel, Shreyaskumar
description
doi_str_mv 10.1016/S1470-2045(17)30624-1
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7939029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_7939029</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_79390293</originalsourceid><addsrcrecordid>eNqljE1LxDAYhIMo7vrxE4T3qNBqkqZt6kGoi-JFWLa9l7RNdyP5WJJ2QX-9ZfXi2dMMM_MMQjcE3xNMsoeKsBzHFLP0luR3Cc4oi8kJWs4xi1PG-enR_0wW6CKED4xJTnB6jhaUF5xnLFuiaS1N651WX5MRLSgLZX8QtpM9VG4YoVYhTBKE7eHZWQmV8J0zIjzCRoZJjwHcAFW5WWHKIyjhfc5UJ-3oZQSVsls9w95EsN6JIIFC7ZXQV-hsEDrI61-9RE-vL_XqLd5PrZH9kRe62XtlhP9snFDN38aqXbN1hyYvkgLTIvn3wTfzY2mx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Tawbi, Hussein A. ; Burgess, Melissa ; Bolejack, Vanessa ; Van Tine, Brain A. ; Schuetze, Scott M. ; Hu, James ; D’Angelo, Sandra ; Attia, Steven ; Riedel, Richard F. ; Priebat, Dennis A. ; Movva, Sujana ; Davis, Lara E. ; Okuno, Scott H. ; Reed, Damon R. ; Crowley, John ; Butterfield, Lisa H. ; Salazar, Ruth ; Rodriguez-Canales, Jaime ; Lazar, Alexander J. ; Wistuba, Ignacio I. ; Baker, Laurence H. ; Maki, Robert G. ; Reinke, Denise ; Patel, Shreyaskumar</creator><creatorcontrib>Tawbi, Hussein A. ; Burgess, Melissa ; Bolejack, Vanessa ; Van Tine, Brain A. ; Schuetze, Scott M. ; Hu, James ; D’Angelo, Sandra ; Attia, Steven ; Riedel, Richard F. ; Priebat, Dennis A. ; Movva, Sujana ; Davis, Lara E. ; Okuno, Scott H. ; Reed, Damon R. ; Crowley, John ; Butterfield, Lisa H. ; Salazar, Ruth ; Rodriguez-Canales, Jaime ; Lazar, Alexander J. ; Wistuba, Ignacio I. ; Baker, Laurence H. ; Maki, Robert G. ; Reinke, Denise ; Patel, Shreyaskumar</creatorcontrib><identifier>ISSN: 1470-2045</identifier><identifier>EISSN: 1474-5488</identifier><identifier>DOI: 10.1016/S1470-2045(17)30624-1</identifier><identifier>PMID: 28988646</identifier><language>eng</language><ispartof>The lancet oncology, 2017-10, Vol.18 (11), p.1493-1501</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids></links><search><creatorcontrib>Tawbi, Hussein A.</creatorcontrib><creatorcontrib>Burgess, Melissa</creatorcontrib><creatorcontrib>Bolejack, Vanessa</creatorcontrib><creatorcontrib>Van Tine, Brain A.</creatorcontrib><creatorcontrib>Schuetze, Scott M.</creatorcontrib><creatorcontrib>Hu, James</creatorcontrib><creatorcontrib>D’Angelo, Sandra</creatorcontrib><creatorcontrib>Attia, Steven</creatorcontrib><creatorcontrib>Riedel, Richard F.</creatorcontrib><creatorcontrib>Priebat, Dennis A.</creatorcontrib><creatorcontrib>Movva, Sujana</creatorcontrib><creatorcontrib>Davis, Lara E.</creatorcontrib><creatorcontrib>Okuno, Scott H.</creatorcontrib><creatorcontrib>Reed, Damon R.</creatorcontrib><creatorcontrib>Crowley, John</creatorcontrib><creatorcontrib>Butterfield, Lisa H.</creatorcontrib><creatorcontrib>Salazar, Ruth</creatorcontrib><creatorcontrib>Rodriguez-Canales, Jaime</creatorcontrib><creatorcontrib>Lazar, Alexander J.</creatorcontrib><creatorcontrib>Wistuba, Ignacio I.</creatorcontrib><creatorcontrib>Baker, Laurence H.</creatorcontrib><creatorcontrib>Maki, Robert G.</creatorcontrib><creatorcontrib>Reinke, Denise</creatorcontrib><creatorcontrib>Patel, Shreyaskumar</creatorcontrib><title>Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial</title><title>The lancet oncology</title><issn>1470-2045</issn><issn>1474-5488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqljE1LxDAYhIMo7vrxE4T3qNBqkqZt6kGoi-JFWLa9l7RNdyP5WJJ2QX-9ZfXi2dMMM_MMQjcE3xNMsoeKsBzHFLP0luR3Cc4oi8kJWs4xi1PG-enR_0wW6CKED4xJTnB6jhaUF5xnLFuiaS1N651WX5MRLSgLZX8QtpM9VG4YoVYhTBKE7eHZWQmV8J0zIjzCRoZJjwHcAFW5WWHKIyjhfc5UJ-3oZQSVsls9w95EsN6JIIFC7ZXQV-hsEDrI61-9RE-vL_XqLd5PrZH9kRe62XtlhP9snFDN38aqXbN1hyYvkgLTIvn3wTfzY2mx</recordid><startdate>20171004</startdate><enddate>20171004</enddate><creator>Tawbi, Hussein A.</creator><creator>Burgess, Melissa</creator><creator>Bolejack, Vanessa</creator><creator>Van Tine, Brain A.</creator><creator>Schuetze, Scott M.</creator><creator>Hu, James</creator><creator>D’Angelo, Sandra</creator><creator>Attia, Steven</creator><creator>Riedel, Richard F.</creator><creator>Priebat, Dennis A.</creator><creator>Movva, Sujana</creator><creator>Davis, Lara E.</creator><creator>Okuno, Scott H.</creator><creator>Reed, Damon R.</creator><creator>Crowley, John</creator><creator>Butterfield, Lisa H.</creator><creator>Salazar, Ruth</creator><creator>Rodriguez-Canales, Jaime</creator><creator>Lazar, Alexander J.</creator><creator>Wistuba, Ignacio I.</creator><creator>Baker, Laurence H.</creator><creator>Maki, Robert G.</creator><creator>Reinke, Denise</creator><creator>Patel, Shreyaskumar</creator><scope>5PM</scope></search><sort><creationdate>20171004</creationdate><title>Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial</title><author>Tawbi, Hussein A. ; Burgess, Melissa ; Bolejack, Vanessa ; Van Tine, Brain A. ; Schuetze, Scott M. ; Hu, James ; D’Angelo, Sandra ; Attia, Steven ; Riedel, Richard F. ; Priebat, Dennis A. ; Movva, Sujana ; Davis, Lara E. ; Okuno, Scott H. ; Reed, Damon R. ; Crowley, John ; Butterfield, Lisa H. ; Salazar, Ruth ; Rodriguez-Canales, Jaime ; Lazar, Alexander J. ; Wistuba, Ignacio I. ; Baker, Laurence H. ; Maki, Robert G. ; Reinke, Denise ; Patel, Shreyaskumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_79390293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tawbi, Hussein A.</creatorcontrib><creatorcontrib>Burgess, Melissa</creatorcontrib><creatorcontrib>Bolejack, Vanessa</creatorcontrib><creatorcontrib>Van Tine, Brain A.</creatorcontrib><creatorcontrib>Schuetze, Scott M.</creatorcontrib><creatorcontrib>Hu, James</creatorcontrib><creatorcontrib>D’Angelo, Sandra</creatorcontrib><creatorcontrib>Attia, Steven</creatorcontrib><creatorcontrib>Riedel, Richard F.</creatorcontrib><creatorcontrib>Priebat, Dennis A.</creatorcontrib><creatorcontrib>Movva, Sujana</creatorcontrib><creatorcontrib>Davis, Lara E.</creatorcontrib><creatorcontrib>Okuno, Scott H.</creatorcontrib><creatorcontrib>Reed, Damon R.</creatorcontrib><creatorcontrib>Crowley, John</creatorcontrib><creatorcontrib>Butterfield, Lisa H.</creatorcontrib><creatorcontrib>Salazar, Ruth</creatorcontrib><creatorcontrib>Rodriguez-Canales, Jaime</creatorcontrib><creatorcontrib>Lazar, Alexander J.</creatorcontrib><creatorcontrib>Wistuba, Ignacio I.</creatorcontrib><creatorcontrib>Baker, Laurence H.</creatorcontrib><creatorcontrib>Maki, Robert G.</creatorcontrib><creatorcontrib>Reinke, Denise</creatorcontrib><creatorcontrib>Patel, Shreyaskumar</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>The lancet oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tawbi, Hussein A.</au><au>Burgess, Melissa</au><au>Bolejack, Vanessa</au><au>Van Tine, Brain A.</au><au>Schuetze, Scott M.</au><au>Hu, James</au><au>D’Angelo, Sandra</au><au>Attia, Steven</au><au>Riedel, Richard F.</au><au>Priebat, Dennis A.</au><au>Movva, Sujana</au><au>Davis, Lara E.</au><au>Okuno, Scott H.</au><au>Reed, Damon R.</au><au>Crowley, John</au><au>Butterfield, Lisa H.</au><au>Salazar, Ruth</au><au>Rodriguez-Canales, Jaime</au><au>Lazar, Alexander J.</au><au>Wistuba, Ignacio I.</au><au>Baker, Laurence H.</au><au>Maki, Robert G.</au><au>Reinke, Denise</au><au>Patel, Shreyaskumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial</atitle><jtitle>The lancet oncology</jtitle><date>2017-10-04</date><risdate>2017</risdate><volume>18</volume><issue>11</issue><spage>1493</spage><epage>1501</epage><pages>1493-1501</pages><issn>1470-2045</issn><eissn>1474-5488</eissn><pmid>28988646</pmid><doi>10.1016/S1470-2045(17)30624-1</doi></addata></record>
fulltext fulltext
identifier ISSN: 1470-2045
ispartof The lancet oncology, 2017-10, Vol.18 (11), p.1493-1501
issn 1470-2045
1474-5488
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7939029
source Elsevier ScienceDirect Journals Complete
title Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T07%3A53%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pembrolizumab%20in%20Advanced%20Soft%20Tissue%20and%20Bone%20Sarcomas:%20Results%20of%20SARC028,%20A%20Multicentre,%20Single%20arm,%20Phase%202%20Trial&rft.jtitle=The%20lancet%20oncology&rft.au=Tawbi,%20Hussein%20A.&rft.date=2017-10-04&rft.volume=18&rft.issue=11&rft.spage=1493&rft.epage=1501&rft.pages=1493-1501&rft.issn=1470-2045&rft.eissn=1474-5488&rft_id=info:doi/10.1016/S1470-2045(17)30624-1&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_7939029%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/28988646&rfr_iscdi=true